Cellectar Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.78

+0.18 (+6.92%)

As of Jun 30, 10:51 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,384.9% upside

Low Target $32.58

Average Target $41.28

High Target $58.47

Current Price $2.78

Current
$2.78

Target
$41.28

$32.58 $41.28 avg $58.47

Scenario Analysis

Bear Case

$32.58

1,071.9%

Low target

Base Case

$41.28

+1,384.9%

Avg target

Bull Case

$58.47

+2,003.2%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$10.19

-72.7% from high

52-Week Low

$2.20

+26.4% from low

Target vs 52W High

$41.28

+305.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%